Gier B, Matveyenko AV, Kirakossian D, Dawson D, Dry SM, and Butler PC
Many insurance applications rely on general medication questions that may not reliably capture GLP-1 use, potentially affecting risk assessment
Looking at this new class of drugs, nobody thought oh, man weve got to try these drugs out in ME/CFS/long COVID or fibromyalgia and yet here we are
Kidney-level sodium excretion
Department of Health and Human Services and the FDA published guidance for pharmaceutical companies that develop and produce antidiabetic medications
With an unwavering commitment to the craft, she is convinced that there is nothing else she was meant to do with her life